›› 2017, Vol. 35 ›› Issue (11): 868-.doi: 10.3969/j.issn.1000-3606.2017.11.017

Previous Articles     Next Articles

Advances in insulin-like growth factor-1 in hypoxic-ischemic encephalopathy

 Reviewer: WU Nan1, CHEN Ting1, Reviser: LIN Lixing2   

  1. 1.The First Clinical Medical College of Lanzhou University, Lanzhou 730000, Gansu, China; 2.The First Affiliated of Lanzhou University, Lanzhou 730000, Gansu, China
  • Received:2017-11-15 Online:2017-11-15 Published:2017-11-15

Abstract:  Hypoxic-ischemic encephalopathy (HIE) is a common cause of neonatal mortality and neurological sequelae. Insulin-like growth factor-1 (IGF-1) is a neurotrophic factor and anti-apoptotic factor that plays an important role in the development and maturation of the central nervous system. In this paper, we intended to provide a new idea and recent progress of HIE by illustrating the mechanism of action of IGF-1 in neuroprotection, nerve repair and neovascularization after brain hypoxia-ischemia injury.